GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » PhenixFIN Corp (NAS:PFX) » Definitions » Change In Receivables
中文

PhenixFIN (PhenixFIN) Change In Receivables : $0.62 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is PhenixFIN Change In Receivables?

PhenixFIN's change in receivables for the quarter that ended in Dec. 2023 was $3.45 Mil. It means PhenixFIN's Accounts Receivable declined by $3.45 Mil from Sep. 2023 to Dec. 2023 .

PhenixFIN's change in receivables for the fiscal year that ended in Sep. 2023 was $-4.10 Mil. It means PhenixFIN's Accounts Receivable increased by $4.10 Mil from Sep. 2022 to Sep. 2023 .

PhenixFIN's Accounts Receivable for the quarter that ended in Dec. 2023 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. PhenixFIN's Days Sales Outstanding for the three months ended in Dec. 2023 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. PhenixFIN's liquidation value for the three months ended in Dec. 2023 was $-74.97 Mil.


PhenixFIN Change In Receivables Historical Data

The historical data trend for PhenixFIN's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhenixFIN Change In Receivables Chart

PhenixFIN Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.61 1.38 -1.87 1.20 -4.10

PhenixFIN Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.27 1.30 -0.10 -4.02 3.45

PhenixFIN Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PhenixFIN  (NAS:PFX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

PhenixFIN's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/7.005*91
=0.00

2. In Ben Graham's calculation of liquidation value, PhenixFIN's accounts receivable are only considered to be worth 75% of book value:

PhenixFIN's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=12.174-87.14+0.75 * 0+0.5 * 0
=-74.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PhenixFIN Change In Receivables Related Terms

Thank you for viewing the detailed overview of PhenixFIN's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


PhenixFIN (PhenixFIN) Business Description

Traded in Other Exchanges
N/A
Address
445 Park Avenue, 10th Floor, New York, NY, USA, 10022
PhenixFIN Corp formerly Medley Capital Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.
Executives
Ellida Mcmillan officer: CFO & Chief Accounting Officer C/O ALCENTRA CAPITAL CORP., 200 PARK AVE, 7TH FL, NEW YORK NY 10166
David A Lorber director C/O FRONTFOUR CAPITAL GROUP LLC, 35 MASON STREET, 4TH FLOOR, GREENWICH CT 06830
Howard Amster director 23811 CHAGRIN BLVD # 200, BEACHWOOD OH 44122-5525
Arthur S Ainsberg director C/O ANGELO, GORDON & CO., L.P., 245 PARK AVENUE, 26TH FLOOR, NEW YORK NY 10167
Karin Hirtler-garvey director 112 W. 34TH STREET, NEW YORK NY 10120
Lowell W Robinson director 470 WEST END AVENUE, NEW YORK NY 10024
Fortress Investment Group Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, 46TH FLOOR, NEW YORK NY 10105
Drawbridge Special Opportunities Fund Lp 10 percent owner C/O FORTRESS INVESTMENT GROUP LLC, 1345 AVENUE OF THE AMERICAS, 46TH FLOOR, NEW YORK NY 10105
Fig Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, 46 FLOOR, NEW YORK NY 10105
Fortress Operating Entity I Lp 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Fig Corp. 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Db Med Investor I Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Drawbridge Special Opportunities Gp Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Drawbridge Special Opportunites Fund Ltd 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Fortress Principal Investment Holdings Iv Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105